Загрузка...
Oncolytic HSV-1 Virotherapy: Clinical Experience and Opportunities for Progress
Oncolytic virotherapy with mutants derived from Herpes simplex virus (HSV) type 1 exhibit significant antitumor effects in preclinical models. Several mutants have now been tested in clinical trials for a variety of cancer types, and all have been found to be safe. While there have been hints of ant...
Сохранить в:
| Опубликовано в: : | Curr Pharm Biotechnol |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4233127/ https://ncbi.nlm.nih.gov/pubmed/21740359 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|